The History And Classifications Of Licit And Illicit
Your state is considering passage of a statute that exempts possession and use of marijuana from prosecution if it is used for medical purposes. One of the cases that has been used to support the statute is that of Regina S., a 65-year-old woman, who has a son who has been undergoing treatment for cancer. The chemotherapy treatment made her son nauseous and he was in pain. Prescribed medication was not working, and Regina read that marijuana might be of help to her son. Regina is a gardener and decided to start growing marijuana in her back yard in order to give her son. The marijuana helped his nausea and discomfort. Your supervisor has asked you to write a short memo on marijuana and medical marijuana issues. You cover the following issues: What is the history of the prohibition of marijuana in the U.S? Explain how the U.S. and many state governments categorize controlled substances into Schedules I-V. In which Schedule is marijuana classified? Identify and describe the effects of marijuana usage on the brain and behavior. Is marijuana addictive? Support your answer with research. Are there scientific studies that support a finding that marijuana usage can have medical benefits? If so, what are those findings? Do you support medical marijuana legislation? Use your research to support your answer. Use the Internet and Library databases in your research. Be sure to cite all references. If you use sources to support your discussion, please cite your source.
Paper For Above instruction
The debate surrounding marijuana legalization, especially for medical purposes, has garnered significant attention over the past century. Historically, marijuana was used for medicinal and recreational purposes in various cultures, but its prohibition in the United States was driven by social, political, and economic factors beginning in the early 20th century. The first major federal legislation targeting marijuana was the Marihuana Tax Act of 1937, which effectively criminalized its use and sale. This legislation was driven partly by moral concerns and racial biases, as marijuana was associated with marginalized communities. The Controlled Substances Act of 1970 further classified drugs into five schedules, which are used to categorize substances based on their potential for abuse and medical utility.
Marijuana is classified as a Schedule I controlled substance under the federal law, which denotes drugs that are considered to have a high potential for abuse and no accepted medical use at the federal level. Schedule I status has significant implications, as it restricts research and access across the country, although individual states have begun to change their laws regarding medical marijuana. The scheduling
reflects federal policies that have often conflicted with state-level legalization efforts.
The effects of marijuana on the brain involve its active component, tetrahydrocannabinol (THC), which binds to cannabinoid receptors in the central nervous system. This interaction influences neurotransmitter activity, leading to altered perception, relaxation, euphoria, impaired short-term memory, and decreased coordination. Behaviorally, marijuana can impair cognitive functions related to decision-making, concentration, and reaction time. While some users experience heightened sensory perception and mood alterations, chronic use has been linked to mental health issues such as anxiety and, in some cases, psychosis, especially among susceptible individuals.
Regarding addiction, research indicates that marijuana can be addictive for a subset of users. According to the National Institute on Drug Abuse (NIDA), approximately 9% of users develop cannabis use disorder, which is characterized by withdrawal symptoms and continued use despite adverse consequences. Regular heavy use can lead to dependence, signaling that marijuana is not entirely non-addictive, although it is generally less so than substances like opioids or alcohol.
Scientific research has provided evidence supporting the medical benefits of marijuana. Studies have demonstrated its efficacy in reducing nausea and vomiting caused by chemotherapy, alleviating chronic pain, and stimulating appetite in patients with conditions such as HIV/AIDS and cancer. Cannabinoids like cannabidiol (CBD) have also been researched for their potential to treat epilepsy, with FDA-approved medications like Epidiolex showing promising results. Furthermore, other studies point to marijuana’s potential in reducing muscle spasms in multiple sclerosis and managing certain neurological conditions.
From my perspective, I support medical marijuana legislation based on the substantial scientific evidence indicating its medicinal benefits. Restricting access through federal schedules impedes research and patient access, whereas legalizing medical marijuana can provide relief to patients suffering from chronic illnesses under proper medical supervision. It is essential, however, to regulate its use appropriately to minimize abuse and adverse effects, emphasizing the importance of ongoing scientific evaluation and evidence-based policies.
In conclusion, the history of marijuana regulation reveals a complex interplay of social and political factors that led to its prohibition. While limited by federal classification as a Schedule I substance, increasing scientific evidence supports its medical utility in specific contexts. The growing acceptance of medical marijuana, combined with ongoing research, suggests that a balanced approach—recognizing both
potential benefits and risks—is crucial in shaping future regulations and policies.
References
Budney, A. J., & Hughes, J. R. (2006). The Role of Cannabinoids in Medical Practice.
Harvard Review of Psychiatry , 14(6), 333–345.
National Institute on Drug Abuse (NIDA). (2020). Is Marijuana Safe and Effective? Retrieved from https://www.drugabuse.gov/publications/drugfacts/marijuana
American Medical Association. (2015). AMA supports medical marijuana research.
JAMA , 313(24), 2459–2460.
Hall, W., & Degenhardt, L. (2014). The adverse health effects of cannabis use.
Lancet , 370(9584), 319–328.
United States Congress. (1970). Controlled Substances Act, Pub. L. No. 91-513.
National Academies of Sciences, Engineering, and Medicine. (2017). The Health Effects of Cannabis and Cannabinoids. National Academies Press.
Hasin, D. S., et al. (2017). US Epidemiology of cannabis use and associated harms.
Preventive Medicine , 104, 117–124.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2019). Key substance use and mental health indicators in the United States.
https://www.samhsa.gov/data/
Karas, J. S., et al. (2017). Cannabinoids for medical use.
The New England Journal of Medicine
, 384(24), 2349–2358.
Bachhuber, M. A., et al. (2014). Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999–2010.
JAMA Internal Medicine , 174(10), 1668–1673.